Movatterモバイル変換


[0]ホーム

URL:


Prijeđi na sadržaj
Wikipedija
Pretraga

Nateglinid

Izvor: Wikipedija
Nateglinid
Klinički podaci
Robne markeFastic, Starlix, Starsis
AHFS/Drugs.comMonografija
Identifikatori
CAS broj105816-04-4
ATC kodA10BX03
PubChem[1][2]60026
DrugBankDB00731
ChemSpider[3]10482084
KEGG[4]C12508 DaY
ChEBICHEBI:146727 DaY
ChEMBL[5]CHEMBL286559 DaY
Hemijski podaci
FormulaC19H27NO3 
Mol. masa317,423
SMILESeMolekuli &PubHem
InChI
InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16-,17-/m1/s1
Key: OELFLUMRDSZNSF-YJEKIOLLSA-N DaY
Farmakokinetički podaci
Poluvreme eliminacije1,5 sati
IzlučivanjeUrinom (83%) i fekalno (10%)
Farmakoinformacioni podaci
Trudnoća?
Pravni status
Način primeneOralno

Nateglinid jeorgansko jedinjenje, koje sadrži 19atomaugljenika i imamolekulsku masu od 317,423Da.[6][7]

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika3
Broj donora vodonika2
Broj rotacionih veza6
Particioni koeficijent[8] (ALogP)4,0
Rastvorljivost[9] (logS, log(mol/L))-5,0
Polarna površina[10] (PSA,Å2)66,4

Reference

[uredi |uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  7. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit
  8. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  9. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  10. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Nateglinid naWikimedijinoj ostavi
Izvor:https://sh.wikipedia.org/w/index.php?title=Nateglinid&oldid=42299365
Kategorije:

[8]ページ先頭

©2009-2026 Movatter.jp